You just read:

Clearbridge BioMedics Partners with the ICR and The Royal Marsden to Demonstrate Label-free Approach in Isolating Heterogeneous Circulating Tumour Cells and PD-L1 Positive CTCs

News provided by

Clearbridge BioMedics

15 Apr, 2016, 09:00 BST